Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: September 12, 2024
Reporting Period: This filing reports on events occurring on September 12, 2024, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing indicates that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated September 2024) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms upcoming presentations by executive officers to representatives of investors and analysts.
Regulatory Disclosure: The information provided, including the referenced Exhibit 99.1, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" under Section 18 of the Exchange Act. It is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated September 2024) for actual financial data, guidance, and strategic outlook, as this 8-K only references the document.
- Verify the date and content of the upcoming investor presentations mentioned by management.
- Confirm that the information in the investor presentation is not automatically incorporated by reference into other SEC filings.